Latest Innovation News

Element 25 Limited has locked in AU$50 million in senior debt from the Northern Australia Infrastructure Facility to expand its Butcherbird manganese project, while advancing its US battery-grade manganese refinery with significant government grants and patent protections.

AdNeo Limited reports sustained positive cash flow and strong contract wins, advancing its strategic acquisition of Learnt Global ahead of schedule while securing $5.5 million in new capital.

BPH Global confirms that the seaweed Sesuvium portulacastrum accumulates valuable metals including gold and lithium, but shifts focus to biological extraction after chemical methods fall short.

Aspermont Limited reports a 7% revenue increase driven by subscription growth and a landmark contract with a top global mining company, while preparing to launch new data products.

Beonic Limited reported a landmark $15.2 million contract win in North Africa alongside strong Q4 FY25 EBITDA profitability and positive cash flow, signaling robust operational momentum heading into FY26.

Arizona Lithium has secured regulatory approval for Phase 1 production at its Prairie Lithium Project in Saskatchewan and raised $4.25 million through an oversubscribed share purchase plan, marking key milestones toward commercial lithium extraction.

Identitii Limited has refinanced a $0.8 million loan with an interest-free facility from its largest shareholder, Beauvais Capital, reducing interest expenses and freeing up company assets.

Prescient Therapeutics has secured FDA Fast Track designation for PTX-100 in treating relapsed Cutaneous T-Cell Lymphoma and dosed the first patient in its Phase 2a trial, supported by a recent $6.8 million capital raise.

Magnetite Mines has increased its Razorback iron ore resource estimate and extended key partnership negotiations, advancing its flagship project’s development. The company also reported promising metallurgical testwork and drew down funding to support ongoing feasibility studies.

Zeotech Limited’s latest quarterly report highlights a robust Preliminary Feasibility Study for its AusPozz™ low-carbon cement project, alongside successful commercial concrete trials and promising methane reduction technology.

Neurizon Therapeutics has made significant strides in developing its lead ALS drug candidate NUZ-001, unveiling a new liquid formulation and submitting a key regulatory response to the FDA. Clinical and preclinical data bolster hopes for broader neurodegenerative applications.

Micro-X has secured its first supply agreement with a leading US healthcare provider for its Rover Plus mobile radiology system, opening access to over 700 facilities nationwide.